IDEAS home Printed from https://ideas.repec.org/a/rvr/journl/201511248.html
   My bibliography  Save this article

La licence obligatoire : outil emblématique de la protection de la santé publique au Sud

Author

Listed:
  • Guennif, Samira

Abstract

Les licences obligatoires sont-elles bonnes pour la santé publique au Sud ? Cet article propose une revue de la littérature qui examine le lien entre cette flexibilité de l’accord ADPIC, visant à suspendre temporairement le monopole d’exploitation associé à la détention d’un brevet et autoriser la production de médicaments génériques, et l’accessibilité des médicaments dans les pays en développement. À la lumière d’un cadre conceptuel précisant les trois dimensions de l’accessibilité, cette revue permettra de confronter systématiquement les arguments théoriques et les faits empiriques en discutant successivement de l’impact de la licence obligatoire sur l’abordabilité, la disponibilité et la qualité des médicaments antisida au Sud. Ainsi, il sera montré que le débat n’est pas tranché concernant l’utilité de la licence obligatoire en matière de promotion de la santé publique tandis que son usage reste de fait rare et compliqué dans l’hémisphère Sud.

Suggested Citation

  • Guennif, Samira, 2015. "La licence obligatoire : outil emblématique de la protection de la santé publique au Sud," Revue de la Régulation - Capitalisme, institutions, pouvoirs, Association Recherche et Régulation, vol. 17.
    • Handle: RePEc:rvr:journl:2015:11248
    as

    Download full text from publisher

    File URL: http://regulation.revues.org/11248
    Download Restriction: no
    File URL: http://regulation.revues.org/pdf/11248
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Samira Guennif & Shyama V. Ramani, 2012. "Explaining divergence in catching-up in pharmaceuticals between India and Brazil using the National System Innovation framework," Post-Print hal-01345868, HAL.
    2. Kenneth Arrow, 1962. "Economic Welfare and the Allocation of Resources for Invention," NBER Chapters, in: The Rate and Direction of Inventive Activity: Economic and Social Factors, pages 609-626, National Bureau of Economic Research, Inc.
    3. Sisule F. Musungu, 2008. "The Use of Flexibilities in TRIPS by Developing Countries: Can They Promot Access to Medicines?," Working Papers id:1649, eSocialSciences.
    4. Sell,Susan K., 2003. "Private Power, Public Law," Cambridge Books, Cambridge University Press, number 9780521819145, November.
    5. Kenneth C. Shadlen & Samira Guennif & Alenka Guzmán & Narayanan Lalitha (ed.), 2011. "Intellectual Property, Pharmaceuticals and Public Health," Books, Edward Elgar Publishing, number 13876.
    6. repec:clg:wpaper:2009-01 is not listed on IDEAS
    7. Krueger, Anne O, 1974. "The Political Economy of the Rent-Seeking Society," American Economic Review, American Economic Association, vol. 64(3), pages 291-303, June.
    8. Guennif, Samira & Ramani, Shyama V., 2012. "Explaining divergence in catching-up in pharma between India and Brazil using the NSI framework," Research Policy, Elsevier, vol. 41(2), pages 430-441.
    9. Jean-Frédéric Morin & Mélanie Bourassa Forcier, 2011. "Pharmaceutical Patent Policy in Developing Countries: Learning from the Canadian Experience," Chapters, in: Kenneth C. Shadlen & Samira Guennif & Alenka Guzmán & Narayanan Lalitha (ed.), Intellectual Property, Pharmaceuticals and Public Health, chapter 8, Edward Elgar Publishing.
    10. Samira Guennif, 2011. "Access to Essential Drugs in Thailand: Intellectual Property Rights and Other Institutional Matters Affecting Public Health in a Developing Country," Chapters, in: Kenneth C. Shadlen & Samira Guennif & Alenka Guzmán & Narayanan Lalitha (ed.), Intellectual Property, Pharmaceuticals and Public Health, chapter 11, Edward Elgar Publishing.
    11. Sell,Susan K., 2003. "Private Power, Public Law," Cambridge Books, Cambridge University Press, number 9780521525398, November.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Iain M. Cockburn & Jean O. Lanjouw & Mark Schankerman, 2016. "Patents and the Global Diffusion of New Drugs," American Economic Review, American Economic Association, vol. 106(1), pages 136-164, January.
    2. Archibugi, Daniele & Filippetti, Andrea, 2010. "The globalisation of intellectual property rights: four learned lessons and four theses," MPRA Paper 21930, University Library of Munich, Germany.
    3. Samira Guennif, 2017. "Is Compulsory Licensing Bad for Public Health? Some Critical Comments on Drug Accessibility in Developing Countries," Applied Health Economics and Health Policy, Springer, vol. 15(5), pages 557-565, October.
    4. Tan Ngoc Vu & Duc Hong Vo & Michael McAleer, 2019. "Rent seeking for export licenses: Application to the Vietnam rice market," Documentos de Trabajo del ICAE 2019-13, Universidad Complutense de Madrid, Facultad de Ciencias Económicas y Empresariales, Instituto Complutense de Análisis Económico.
    5. Bayer, Patrick & Marcoux, Christopher & Urpelainen, Johannes, 2013. "Leveraging private capital for climate mitigation: Evidence from the Clean Development Mechanism," Ecological Economics, Elsevier, vol. 96(C), pages 14-24.
    6. Ramani, Shyama V. & Urias, Eduardo, 2018. "When access to drugs meets catch-up: Insights from the use of CL threats to improve access to ARV drugs in Brazil," Research Policy, Elsevier, vol. 47(8), pages 1538-1552.
    7. Samira Guennif, 2007. "Global harmonisation of intellectual property rights and local impact. Patent and access to medicines in developing countries under TRIPS and TRIPS plus provisions [Harmonisation globale des systèm," Post-Print hal-01345869, HAL.
    8. Anne Roemer-Mahler, 2013. "Business conflict and global politics: The pharmaceutical industry and the global protection of intellectual property rights," Review of International Political Economy, Taylor & Francis Journals, vol. 20(1), pages 121-152, February.
    9. Emilie Cloatre & Robert Dingwall, 2013. "“Embedded regulation:” The migration of objects, scripts, and governance," Regulation & Governance, John Wiley & Sons, vol. 7(3), pages 365-386, September.
    10. Suma Athreye & Lucia Piscitello & Kenneth C. Shadlen, 2020. "Twenty-five years since TRIPS: Patent policy and international business," Journal of International Business Policy, Palgrave Macmillan, vol. 3(4), pages 315-328, December.
    11. Paola Perez-Aleman & Tommaso Ferretti, 2023. "Creating innovation capabilities for improving global health: Inventing technology for neglected tropical diseases in Brazil," Journal of International Business Policy, Palgrave Macmillan, vol. 6(1), pages 84-114, March.
    12. Mehrdad Vahabi, 2011. "Appropriation, violent enforcement, and transaction costs: a critical survey," Public Choice, Springer, vol. 147(1), pages 227-253, April.
    13. Daniel Berliner & Aseem Prakash, 2012. "From norms to programs: The United Nations Global Compact and global governance," Regulation & Governance, John Wiley & Sons, vol. 6(2), pages 149-166, June.
    14. Francesca Spigarelli & Hao Way, 2012. "The rising Chinese pharmaceutical industry: local champions vs global players," Working Papers 1206, c.MET-05 - Centro Interuniversitario di Economia Applicata alle Politiche per L'industria, lo Sviluppo locale e l'Internazionalizzazione.
    15. Mike W Peng & David Ahlstrom & Shawn M Carraher & Weilei (Stone) Shi, 2017. "An institution-based view of global IPR history," Journal of International Business Studies, Palgrave Macmillan;Academy of International Business, vol. 48(7), pages 893-907, September.
    16. Lee, Keun & Malerba, Franco, 2017. "Catch-up cycles and changes in industrial leadership:Windows of opportunity and responses of firms and countries in the evolution of sectoral systems," Research Policy, Elsevier, vol. 46(2), pages 338-351.
    17. Madison Cartwright, 2021. "Business conflict and international law: The political economy of copyright in the United States," Regulation & Governance, John Wiley & Sons, vol. 15(1), pages 152-167, January.
    18. Suzuki, Mao, 2020. "Profits before patients? Analyzing donors’ economic motives for foreign aid in the health sector," World Development, Elsevier, vol. 132(C).
    19. Jean‐Frédéric Morin & Madison Cartwright, 2020. "The US and EU’s Intellectual Property Initiatives in Asia: Competition, Coordination or Replication?," Global Policy, London School of Economics and Political Science, vol. 11(5), pages 557-568, November.
    20. Tristan Auvray & Cédric Durand & Joel Rabinovich & Cecilia Rikap, 2021. "Corporate financialization’s conservation and transformation: from Mark I to Mark II," Review of Evolutionary Political Economy, Springer, vol. 2(3), pages 431-457, December.

    More about this item

    Keywords

    pays en développement; santé publique; propriété intellectuelle; accessibilité des médicaments; licence obligatoire; VIH/Sida; antirétroviraux; southern countries; public health; patent; essential drugs accessibility; compulsory license; HIV/AIDS; antiretrovirals; países en desarrollo; salud pública; propiedad intelectual; accesibilidad de los medicamentos; licencia obligatoria; VIH/Sida; antiretrovirales;
    All these keywords.

    JEL classification:

    • I18 - Health, Education, and Welfare - - Health - - - Government Policy; Regulation; Public Health
    • K11 - Law and Economics - - Basic Areas of Law - - - Property Law
    • K32 - Law and Economics - - Other Substantive Areas of Law - - - Energy, Environmental, Health, and Safety Law
    • K33 - Law and Economics - - Other Substantive Areas of Law - - - International Law

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:rvr:journl:2015:11248. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Pascal Seppecher (email available below). General contact details of provider: https://theorie-regulation.org/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.